Global Clostridium Diagnostics Industry

Global Clostridium Diagnostics Industry

  • July 2020 •
  • 378 pages •
  • Report ID: 5899232 •
  • Format: PDF
Global Clostridium Diagnostics Market to Reach $4.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Clostridium Diagnostics estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at aCAGR of 13.9% over the period 2020-2027. Immunoassays, one of the segments analyzed in the report, is projected to record 15.4% CAGR and reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular Diagnostics segment is readjusted to a revised 9.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $512.3 Million, While China is Forecast to Grow at 18.4% CAGR

The Clostridium Diagnostics market in the U.S. is estimated at US$512.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.6% and 12.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.We bring years of research experience to this 9th edition of our report. The 378-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Chrono-log Corporation
  • Corgenix
  • Diazyme Laboratories
  • F. Hoffmann-La Roche AG
  • Fujirebio US, Inc.
  • Hologic, Inc.
  • QIAGEN GmbH
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.